NIAID Centralized Sequencing Protocol | MicrobiomeTrials← Back to trialsNCT03206099
NIAID Centralized Sequencing Protocol
RecruitingOBSERVATIONAL
Trial Details
Start: 2017-07-31Est. Completion: 2042-07-01
Enrollment target: 20,000 participants Locations- Children's National Health System, Washington D.C., District of Columbia, United States
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
AsthmaAsthma in ChildrenAllergyRhinitis, AllergicAtopic DermatitisAllergen Immunotherapy
The summary is available at --\> https://www.finnatopy.fi/summary
Tampere, FinlandCompleted Dec 2032
Atopic Dermatitis
This is a multi-center, randomized, double-blind, parallel, placebo-controlled phase 2 clinical study. A total of 403 ad…
Beijing, ChinaCompleted Aug 18, 2026